Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP822655.RASYCuqPhR4sLu1413VF5K74XGXxsvBV6CNXR_yz03AXc130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822655.RASYCuqPhR4sLu1413VF5K74XGXxsvBV6CNXR_yz03AXc130_provenance.
• NP786815.RAY88FPq6dEjigyIc5jMxj3mJOEbHTK5FDuBeZN1BYnXs130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786815.RAY88FPq6dEjigyIc5jMxj3mJOEbHTK5FDuBeZN1BYnXs130_provenance.
• assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP986169.RAY_hDRNLB4OYxcTTVn06JdlZD53MvlNPjn4zESLqQjU8130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986169.RAY_hDRNLB4OYxcTTVn06JdlZD53MvlNPjn4zESLqQjU8130_provenance.
• NP986174.RAceCC6sM0fxPtvu29V-o0OoSndxC5NlVgD9mocF3pFjo130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986174.RAceCC6sM0fxPtvu29V-o0OoSndxC5NlVgD9mocF3pFjo130_provenance.
• NP329066.RAqtMufLLLflvEVUE4LCBC4rFvAzc3Yndt42kpqs6rQpU130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329066.RAqtMufLLLflvEVUE4LCBC4rFvAzc3Yndt42kpqs6rQpU130_provenance.
• NP879811.RAtmecycRj7JGmEX-CS9xBldOSRoj0lRIb0D7nmfRJFrU130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879811.RAtmecycRj7JGmEX-CS9xBldOSRoj0lRIb0D7nmfRJFrU130_provenance.
• NP881575.RAlBcfUWE9r8JRyXt4lSYk77D2YEEviYSrwTlHtm-RR0w130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881575.RAlBcfUWE9r8JRyXt4lSYk77D2YEEviYSrwTlHtm-RR0w130_provenance.
• NP986171.RAs2RiJZqAncqpkSNvN9o0Q2HHZrDlxhdLBVplWdvki5s130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986171.RAs2RiJZqAncqpkSNvN9o0Q2HHZrDlxhdLBVplWdvki5s130_provenance.
• NP986175.RAnxhVvEZcbFL1UFKL_pOvz01dMF38HMcSxzA5oMtUXHU130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986175.RAnxhVvEZcbFL1UFKL_pOvz01dMF38HMcSxzA5oMtUXHU130_provenance.
• NP986176.RApluthFBiqZqctODHLGGwFyXZzGSnnH7bPgjkG77esRw130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986176.RApluthFBiqZqctODHLGGwFyXZzGSnnH7bPgjkG77esRw130_provenance.
• NP590124.RAL84hS1FQG0esdBtnwRYR6sfEj4B9Z_ruEJQyUJhFx74130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590124.RAL84hS1FQG0esdBtnwRYR6sfEj4B9Z_ruEJQyUJhFx74130_provenance.
• NP644133.RAILpBPCqu40dzMIBKYrM5id2IciX6jzpdeIhceIuOEkM130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644133.RAILpBPCqu40dzMIBKYrM5id2IciX6jzpdeIhceIuOEkM130_provenance.
• NP326670.RAHQVXgXPMda0DqgjHkSQTIBMp4AE0WV6KyKwTJCGFB9Q130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326670.RAHQVXgXPMda0DqgjHkSQTIBMp4AE0WV6KyKwTJCGFB9Q130_provenance.
• NP986168.RAEtYjRpcTSXXgF4IRekqw3eHa-PXelydQ5EbBa-96lbA130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986168.RAEtYjRpcTSXXgF4IRekqw3eHa-PXelydQ5EbBa-96lbA130_provenance.
• NP848252.RAG2CdHlL-Nnv7KwjzIcGfu2BU1k81cCLzPDtBCx0zxr8130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848252.RAG2CdHlL-Nnv7KwjzIcGfu2BU1k81cCLzPDtBCx0zxr8130_provenance.
• NP986165.RA4N5_LSNnrA6q9KCqxTttZbv6pfD5_HORWDErDwriaoQ130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986165.RA4N5_LSNnrA6q9KCqxTttZbv6pfD5_HORWDErDwriaoQ130_provenance.
• NP986170.RA1LKvpJ9CMja4_R0YP0k5BZwIGWByEqJy3Y4prCpeBnk130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986170.RA1LKvpJ9CMja4_R0YP0k5BZwIGWByEqJy3Y4prCpeBnk130_provenance.
• NP986172.RA7Ojf47s_2sEX6s3lYYAvvdr5gZW10OnBzlT71MEobHI130_assertion description "[Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-?B and p38 and induced apoptosis in lymphoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986172.RA7Ojf47s_2sEX6s3lYYAvvdr5gZW10OnBzlT71MEobHI130_provenance.